The distributions of group means, standard deviations, minimum and maximum values for microglia mean cell body volume, microglia mean cell body number, and volume of DG are shown in Fig. 1, Fig. 2 and Fig. 3. Two-way ANOVA (group × sex) indicated a statistically significant difference among the groups (F2,27 = 12.01; p < 0.01; Table 1) with no main effect for sex; and no interaction. Further analysis with Tukey's post hoc tests revealed that, as compared with controls (114.39 + 20.62; 95% C.L. 96.57–132.21), microglia mean cell body volume of the 30 ppm Pb exposure CH5424802 price group was significantly larger (154.92 + 40.35; 95% C.L. 137.10–172.74), t = 3.30, p < 0.01. As compared with controls,
the microglia mean cell body volume of the 330 ppm Pb exposure group (96.09 + 14.49; 95% C.L. 78.27–113.91) did not differ significantly, t = 1.49, p = 0.15, and thus a dose–response effect was not observed. Two-way ANOVA (group × sex) indicated a statistically significant difference among the groups (F2,27 = 24.49; p < 0.01; Table 1) with no main effect for sex; and no interaction. Tukey's post hoc tests revealed that, as compared with controls (7116 + 1363; 95% C.L. 6501–7730), the microglia mean cell body number of the 30 ppm Pb exposure group was significantly cancer metabolism signaling pathway decreased (5274 + 808; 95% C.L 4660–5889), t = −4.35, p < 0.01. Similarly, as compared with controls, the microglia mean cell body number of the 330 ppm Pb exposure
group was significantly decreased (4184 + 423; C.L. 3569–4789), t = −6.92, p < 0.01. Microglia mean cell body number of the 30 ppm and 330 Pb exposure group differed significantly, t = −2.57, p = 0.02, suggesting a dose response relationship between DG microglia number and blood Pb level. Thus, from 30 animals, we attempted to predict DG microglia mean cell body number from blood Pb levels using simple linear regression analysis. A moderate linear association
was suggested. The slope of the regression line was significantly less than zero, suggesting that as blood Pb level increased, the number of DG microglia decreased (slope = −170; 95% C.L. −240 to −101; t28 = −5.02; p < 0.01; DG microglia = 6505 + (−170 × blood Pb level); adj r2 = 0.47). ADP ribosylation factor Two-way ANOVA (group × sex) indicated a statistically significant difference among the groups (F2,27 = 11.50; p < 0.01; Table 1); with no main effect for sex, and no interaction. Tukey’s post hoc tests revealed that, as compared with controls (0.38 mm3 + 0.06; 95% C.L. 0.35–0.41), the DG volume means of the 30 ppm Pb exposure group (0.29 mm3 + 0.03; 95% C.L 0.26–0.32), (t = −4.65, p < 0.01); and the 330 ppm Pb exposure group (0.31 mm3 + 0.04; C.L. 0.28–0.34), (t = −3.35, p < 0.01); were significantly decreased. DG volumes of the 30 ppm and 330 ppm Pb exposure groups were not statistically significant (t = −1.30, p = 0.20) suggesting that the relationship between blood Pb level and DG volume was not linear.